RecruitingNot ApplicableNCT07367581

Costotransverse Foramen Block Versus Thoracic Paravertebral Block in Thoracotomy for Lung Cancer

Costotransverse Foramen Block Versus Thoracic Paravertebral Block in Thoracotomy for Lung Cancer: A Randomized Controlled Trial


Sponsor

National Cancer Institute, Egypt

Enrollment

70 participants

Start Date

Jan 24, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims to compare the costotransverse foramen block (CTFB) with thoracic paravertebral block (TPVB) in patients undergoing thoracotomy for lung cancer.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This study is comparing two types of nerve block techniques for pain relief after open chest surgery (thoracotomy) for lung cancer: a costotransverse foramen block (a newer technique) versus a thoracic paravertebral block (the current standard). The goal is to find out which provides better pain control. **You may be eligible if...** - You are between 18 and 65 years old - You have a BMI between 18 and 35 - You are scheduled for open chest surgery for lung cancer - You are classified as ASA physical status II or III (moderate health issues) **You may NOT be eligible if...** - You have an allergy to local anesthetic medications - You have a history of psychological disorders - You have conditions that prevent regional anesthesia (local infection, nerve disease, bleeding problems) - You have severe respiratory, heart, liver, or kidney disease - You are extremely obese (morbidly obese) - You are on chronic pain medication Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERCostotransverse foramen block

Patients will receive an ipsilateral ultrasound-guided costotransverse foramen block with injection of 20 ml bupivacaine 0.25%.

OTHERThoracic paravertebral plane block

Patients will receive an ipsilateral ultrasound-guided thoracic paravertebral plane block with injection of 20 ml bupivacaine 0.25%.


Locations(1)

Cairo University

Cairo, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07367581


Related Trials